Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) Tops Q4 EPS by 6c, Offers Guidance, Approves $500M Buyback

May 7, 2019 6:16 AM EDT

Haemonetics (NYSE: HAE) reported Q4 EPS of $0.61, $0.06 better than the analyst estimate of $0.55. Revenue for the quarter came in at $249.3 million versus the consensus estimate of $250.63 million.

GUIDANCE:

Haemonetics sees FY2020 EPS of $2.80-$3.00, versus the consensus of $2.89.

SHARE REPURCHASE PROGRAM The Company announced that its Board of Directors recently authorized the repurchase of... More